Neurofeedback and Attention-Deficit/Hyperactivity-Disorder (ADHD) in Children

Autor:	Martha Mack, C. Richard Clark, Michelle Aniftos, Martijn Arns, Mark Trullinger, Roger deBeus
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	medicine.medical_specialty Evidence-based practice SYMPTOMS Remission medicine.medical_treatment HYPERKINETIC-CHILD Behaviour therapy BETA Review Effect size THERAPY Article law.invention 03 medical and health sciences 0302 clinical medicine ELECTROENCEPHALOGRAPHIC BIOFEEDBACK Randomized controlled trial law Outcome Assessment Health Care medicine Attention deficit hyperactivity disorder Humans ADHD EEG Child Applied Psychology STIMULANTS business.industry Publication bias Neurofeedback SMR medicine.disease EFFICACY 030227 psychiatry Stimulant Neuropsychology and Physiological Psychology Systematic review Attention Deficit Disorder with Hyperactivity Practice Guidelines as Topic Physical therapy TRIAL business 030217 neurology & neurosurgery
Zdroj:	Applied Psychophysiology and Biofeedback
ISSN:	1090-0586
Popis:	Stimulant medication and behaviour therapy are the most often applied and accepted treatments for Attention-Deficit/Hyperactivity-Disorder (ADHD). Here we explore where the non-pharmacological clinical intervention known as neurofeedback (NFB), fits on the continuum of empirically supported treatments, using standard protocols. In this quantitative review we utilized an updated and stricter version of the APA guidelines for rating ‘well-established’ treatments and focused on efficacy and effectiveness using effect-sizes (ES) and remission, with a focus on long-term effects. Efficacy and effectiveness are compared to medication and behaviour therapy using benchmark studies. Only recent systematic reviews and meta-analyses as well as multi-centre randomized controlled trials (RCT’s) will be included. Two meta-analyses confirmed significant efficacy of standard neurofeedback protocols for parent and teacher rated symptoms with a medium effect size, and sustained effects after 6–12 months. Four multicenter RCT’s demonstrated significant superiority to semi-active control groups, with medium-large effect sizes end of treatment or follow-up and remission rates of 32–47%. Effectiveness in open-label studies was confirmed, no signs of publication bias were found and no significant neurofeedback-specific side effects have been reported. Standard neurofeedback protocols in the treatment of ADHD can be concluded to be a well-established treatment with medium to large effect sizes and 32–47% remission rates and sustained effects as assessed after 6–12 months.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7366af3a0e1bb44642554608fb7aae09 https://doi.org/10.1007/s10484-020-09455-2 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.